Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine
J N Sarkaria1, E C Busby, R S Tibbetts
1Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA. sarkaria.jann@mayo.edu
Abstract:
Caffeine exposure sensitizes tumor cells to ionizing radiation and other genotoxic agents. The radiosensitizing effects of caffeine are associated with the disruption of multiple DNA damage-responsive cell cycle checkpoints. The similarity of these checkpoint defects to those seen in ataxia-telangiectasia (A-T) suggested that caffeine might inhibit one or more components in an A-T mutated (ATM)-dependent checkpoint pathway in DNA-damaged cells. We now show that caffeine inhibits the catalytic activity of both ATM and the related kinase, ATM and Rad3-related (ATR), at drug concentrations similar to those that induce radiosensitization. Moreover, like ATM-deficient cells, caffeine-treated A549 lung carcinoma cells irradiated in G2 fail to arrest progression into mitosis, and S-phase-irradiated cells exhibit radioresistant DNA synthesis. Similar concentrations of caffeine also inhibit gamma- and UV radiation-induced phosphorylation of p53 on Ser15, a modification that may be directly mediated by the ATM and ATR kinases. DNA-dependent protein kinase, another ATM-related protein involved in DNA damage repair, was resistant to the inhibitory effects of caffeine. Likewise, the catalytic activity of the G2 checkpoint kinase, hChk1, was only marginally suppressed by caffeine but was inhibited potently by the structurally distinct radiosensitizer, UCN-01. These data suggest that the radiosensitizing effects of caffeine are related to inhibition of the protein kinase activities of ATM and ATR and that both proteins are relevant targets for the development of novel anticancer agents.
Insights
Caffeine enhances cancer cell sensitivity to radiation by disrupting DNA damage checkpoints. This effect stems from caffeine inhibiting key kinases like ATM and ATR, crucial for DNA repair and cell cycle control.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Caffeine is known to sensitize tumor cells to genotoxic agents like ionizing radiation.
- This radiosensitization is linked to the disruption of DNA damage-responsive cell cycle checkpoints.
- Similarities between caffeine's effects and defects in ataxia-telangiectasia (A-T) suggested a potential inhibition of ATM-dependent pathways.
Purpose of the Study:
- To investigate the molecular mechanisms underlying caffeine's radiosensitizing effects.
- To determine if caffeine inhibits ATM (ataxia-telangiectasia mutated) and/or ATR (ATM and Rad3-related) kinases.
- To explore the role of ATM and ATR inhibition in caffeine-induced radiosensitization and cell cycle checkpoint abrogation.
Main Methods:
- Assessed the catalytic activity of ATM and ATR kinases in the presence of caffeine.
- Examined the effects of caffeine on cell cycle progression in irradiated lung carcinoma cells (A549).
- Measured the phosphorylation of p53 on Ser15 following gamma- and UV radiation in caffeine-treated cells.
- Evaluated the impact of caffeine on other related kinases like DNA-dependent protein kinase and hChk1.
Main Results:
- Caffeine inhibited the catalytic activity of both ATM and ATR kinases at concentrations relevant to radiosensitization.
- Caffeine-treated cells failed to arrest in G2 phase after irradiation and exhibited radioresistant DNA synthesis in S-phase.
- Caffeine reduced gamma- and UV radiation-induced p53 phosphorylation at Ser15.
- DNA-dependent protein kinase and hChk1 showed relative resistance to caffeine's inhibitory effects.
Conclusions:
- Caffeine's radiosensitizing properties are attributed to the inhibition of ATM and ATR protein kinase activities.
- ATM and ATR are identified as key molecular targets mediating caffeine's effects on DNA damage response and radiosensitization.
- These findings suggest ATM and ATR as potential targets for developing novel anticancer agents aimed at enhancing radiotherapy efficacy.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
cAMP-dependent Protein Kinase Pathways


